Empreses emergents
2016
ALBAJUNA THERAPEUTICS SLDesenvolupament d'anticossos terapèutics contra el VIH
Adreça
Avinguda de la Generalitat 152, 08174, Espanya
Propietat CERCA
Badalona, Spain
1995
Institut de Recerca de la Sida (IRSICAIXA)
Àrees d'estat i deeptech
Estat de l'empresa i àrees de tecnologia profunda de l'empresaEstat de l'empresa
Àrea DeepTech
Informació sobre la spin-off
Descripció de l'empresa
AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, is developing a new treatment strategy based on monoclonal antibodies with great potential to neutralize HIV and activate the "natural killer" cells responsible for destroying cells infected by the virus
Descripció del producte
Developing a new treatment strategy based on monoclonal antibodies with great potential to neutralize HIV and activate the "natural killer" cells responsible for destroying cells infected by the virus.The three candidate molecules available have demonstrated in vitro results that are 100 times more powerful than those obtained to date by any other molecule with similar characteristics.
The in vitro results of the candidate molecules have demonstrated a neutralizing power 100 times greater than that of any other molecule developed to date, and the participation of Grifols in this research company will accelerate its development.
The in vitro results of the candidate molecules have demonstrated a neutralizing power 100 times greater than that of any other molecule developed to date, and the participation of Grifols in this research company will accelerate its development.